Adverio Pharma GmbH
Records under this name other than the patents Adverio Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 27 patents it holds.
Showing 1 to 4 of 4 · Back to Adverio Pharma GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,802,847 | Process for preparing substituted 5-fluoro-1H-pyrazolopyridines Formerly held In force · High confidence | In force | High confidence | |
| US 9,266,885 | Substituted 5-Fluoro-1H-PYRAZOLOPYRIDINES and Their Use Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,189,856 | Use of SGC Stimulators, SGC Activators, Alone and Combinations with PDE5 Inhibitors for the Treatment of Systemic Sclerosis (SSC). Lapsed on the fee record Ended Jan 29, 2023 · High confidence | Lapsed on the fee record | Ended Jan 29, 2023 | High confidence |
| US 6,743,798 | Substituted Pyrazole Derivatives Condensed with Six-Membered Heterocyclic Rings Term ended Term ended Jul 16, 2019 · High confidence | Term ended | Term ended Jul 16, 2019 | High confidence |